Today’s AI Top Pick: VC
9/30/2026 · Highly Shorted Oversold screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live VC price forecast →
Visteon (VC) is the best risk/reward entry in this pool because it uniquely combines a deeply oversold tape with genuine fundamental quality and clean multi-timeframe confirmation. The RSI sits at 23.54 (well below the 35 screen threshold), and the forecast tape shows all three available timeframes pointing up across the mid and long horizons: 4-hour fc_long_pct of 12.81%, 1-day fc_long_pct of 15.31%, and 1-week fc_long_pct of 16.04%, with fc_mid_pct of 13.69% on the weekly. Critically, the stock is NOT at the top of its range — position_in_21bar_range_pct is 0 on both the 1-day and 1-week, meaning price is sitting at the low end of its 21-bar range with a -21.05% weekly drawdown. That is a textbook oversold bounce setup, not a chase. Bullish probability is 1.0 with near_term_bullish at 1.0, confirming the near-term tape agrees. The fundamentals justify the thesis rather than merely passing the screen. Forward P/E of 8.32 and a PEG of 0.45 signal a cheap entry relative to growth, with epsNextY of 23.13 and an operating margin of 7.33%. Analyst sentiment is constructive: a Recom of 1.83 (near strong-buy) and a target upside of 48.2%. Recent headlines reinforce this — JP Morgan maintained its Overweight rating on Visteon and only trimmed its price target to $145, which is a sign of conviction rather than a downgrade. Short float of 15.58% provides a live short-squeeze fuel source on any positive momentum. Why TODAY and not waiting: the multi-timeframe forecast agreement is rare in this pool, and the stock is at the bottom of its range with negative drawdowns across all horizons — there is no better entry than the current low. Waiting risks a relief bounce that leaves you chasing. The only caution is that the 4-hour fc_long_pct (12.81%) trails the daily and weekly, suggesting the very shortest-term momentum is slightly less bullish, but this is a minor inconsistency that does not undermine the multi-timeframe bullish alignment. The setup is a high-conviction oversold reversion with a clear invalidation level.
- Automotive sector exposure — VC is a auto-parts supplier, vulnerable to any auto-demand or recession deterioration
- 4-hour fc_long_pct of 12.81% trails the daily (15.31%) and weekly (16.04%), indicating the shortest-term momentum is the weakest link
- Short float of 15.58% is a double-edged sword — high float can amplify downside on negative catalysts
- Operating margin of only 7.33% leaves little margin of error if guidance is cut
- Negative perfYear of -28.01% confirms a persistent downtrend that could persist if the market stays risk-averse
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | VC | BUY NOW | 11.8 | Deeply oversold (RSI 23.54) with clean multi-timeframe bullish forecast agreement and cheap valuation (fwdPe 8.32, PEG 0.45) — best risk/reward entry. |
| 2 | LRN | BUY PULLBACK | 11.5 | Strong fundamentals and a Capital Markets Day catalyst, but the 1-week fc_long_pct of -4.17% and extreme daily outlier reduce tape cleanliness. |
| 3 | YELP | BUY NOW | 11.2 | Cheap (fwdPe 7.23), oversold (RSI 33.26), bullish across all timeframes, but a 'reasons to avoid' headline is a minor landmine. |
| 4 | PATK | BUY PULLBACK | 10.8 | Solid fundamentals (fwdPe 13.11) and bullish multi-timeframe tape, but the 4h fc_long_pct of 60.29% is an extreme outlier suggesting a one-bar move. |
| 5 | BKV | BUY PULLBACK | 10.5 | Energy name with strong analyst backing (Evercore Strong-Buy) and cheap fwdPe 11.48, but negative operating margin (-0.86%) is a caution. |
| 6 | NCNO | BUY PULLBACK | 10.2 | Oversold (RSI 32.28) with bullish multi-timeframe forecast, but expensive on trailing P/E of 59.5 despite cheap forward of 11.44. |
| 7 | OWL | BUY PULLBACK | 9.9 | Oversold with a 'sellover looks overdone' catalyst, but P/E of 117.32 and high debtEq of 2.18 make it a value trap risk. |
| 8 | AAP | BUY PULLBACK | 9.6 | Cheap fwdPe 10.15 and bullish tape, but negative salesYoY of -1.3% and thin profitMargin of 0.97% limit upside. |
| 9 | TPB | BUY PULLBACK | 9.3 | Deeply oversold (RSI 23.8) with a rating upgrade catalyst, but PEG of 8.34 signals stretched valuation on growth. |
| 10 | WHR | BUY PULLBACK | 9.0 | Extremely cheap (ps 0.13) and bullish multi-timeframe tape, but negative perfYear of -60.87% and declining salesYoY of -3.92%. |
| 11 | SAH | BUY PULLBACK | 8.7 | Cheap (fwdPe 7.83) and oversold (RSI 27.08), but declining margins and a 'time to sell' headline are headwinds. |
| 12 | ENPH | WAIT | 8.4 | Oversold with bullish fundamentals, but near_term_bullish of only 0.4 and negative salesYoY of -10.41% warrant caution. |
| 13 | AREC | BUY PULLBACK | 8.1 | Short squeeze fuel (15.97% float) with an acquisition catalyst, but negative operating margin of -31609.89% and profitMargin of -39087.51% are extreme. |
| 14 | TRIP | WAIT | 7.8 | Cheap on PS of 0.55 with bullish forecast, but P/E of 831.68 and a 'bad investment' headline are major red flags. |
| 15 | WU | BUY PULLBACK | 7.5 | Very cheap (fwdPe 3.94) and oversold (RSI 27.2), but a Cantor Underweight downgrade with a $6 target caps upside. |
| 16 | POST | BUY PULLBACK | 7.2 | Oversold with bullish multi-timeframe tape, but negative epsNextY of -5.93% and a 'questionable fundamentals' headline. |
| 17 | PPC | WAIT | 6.9 | Cheap (fwdPe 9.61) and bullish tape, but thin profitMargin of 2.96% and declining salesYoY of 1.42% limit appeal. |
| 18 | GT | BUY PULLBACK | 6.6 | Oversold with a bullish 'Wall Street's mistake' narrative, but negative profitMargin of -14.37% and perfYear of -33.33%. |
| 19 | REAL | WAIT | 6.3 | Oversold with a '43% undervalued' catalyst, but negative profitMargin of -10.82% and P/E of null signal unprofitability. |
| 20 | TNXP | WAIT | 6.0 | Biotech with a Medicare payer catalyst, but negative operating margin of -568.43% and perfYear of -61.03% are high-risk. |
| 21 | CABA | WAIT | 5.7 | Oversold biotech with a Buy rating, but negative ROE of -93.2% and no profitability metrics. |
| 22 | HROW | WAIT | 5.4 | Cheap on fwdPe 14.29 with a Moderate Buy rating, but negative ROE of -114.8% and profitMargin of -13.51%. |
| 23 | PDYN | WAIT | 5.1 | Speculative AI name with a FANUC collaboration catalyst, but negative operating margin of -360.67% and perfYear of -39.3%. |
| 24 | JBIO | WAIT | 4.8 | Oversold biotech with bullish forecast, but negative ROE of -47.78% and no profitability metrics. |
| 25 | BW | WAIT | 4.5 | Short-squeeze fuel with a $130M deal catalyst, but negative profitMargin of -12.79% and perfYear of 82.7% volatility. |
| 26 | ABR | WAIT | 4.2 | Oversold with bullish forecast, but P/E of 61.84 and negative perfYear of -66.97% are high-risk. |
| 27 | LRMR | WAIT | 3.9 | Oversold biotech with a sector-recovery catalyst, but negative ROE of -139.63% and no profitability metrics. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord